News Releases

May 29, 2013

RepliCel and Shiseido Announce Collaboration and Technology Transfer Framework Agreement and Exclusive Geographic Technology License
Tokyo, Japan and Vancouver, Canada – May 29, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX:RP) and Shiseido Company,... Read full article

May 23, 2013

Dr. Jerry Shapiro to Present RepliCel Data to European Academy of Dermatology and Venereology in Poland
VANCOUVER, BC – May 23, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX: RP), reports that one of its... Read full article

May 21, 2013

RepliCel Announces Closing of Private Placement
VANCOUVER, BC – May 21, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF and CNSX: RP) is pleased to announce... Read full article

April 30, 2013

RepliCel Announces New Tendon Repair Technology Based on its Hair Follicle Cellular Expertise
VANCOUVER, BC – April 30, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) (CDNX:RP) is pleased to announce that it... Read full article

April 30, 2013

RepliCel Presents Further Clinical Data and Corporate Update at its Annual General Meeting of Shareholders
VANCOUVER, BC – June 11, 2012 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCQB:REPCF) presented significant new data from its Phase I/IIa... Read full article

April 18, 2013

RepliCel Receives Issue Notification from the United States Patent and Trademark Office Protecting Methods of Preparing Dermal Sheath Cup Cells for its Hair Regeneration Technology
VANCOUVER, BC – April 18, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX:RP) is pleased to announce that it... Read full article

April 10, 2013

RepliCel Announces Closing of Private Placement
VANCOUVER, BC – April 10, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF and CNSX: RP) is pleased to announce... Read full article

February 19, 2013

RepliCel to Present at the 11th Annual BioPartnering North America Conference
Vancouver Convention Centre, Vancouver, BC, February 24-26th, 2013 VANCOUVER, BC – February 19th 2013 – RepliCel Life Sciences Inc (the “Company” or “RepliCel”) (OTCBB:... Read full article

February 8, 2013

RepliCel Announces Re-Pricing of Warrants
VANCOUVER, BC – February 8, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB: REPCF) (CNSX:RP) announces that it has received Exchange... Read full article

February 4, 2013

RepliCel to Meet with German Competent Authority on its RCH-01 Autologous Hair Cell Manufacturing Process
Phase II Dose Ranging Trial Planned for 2013 VANCOUVER, BC – February 4, 2013 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB:... Read full article